HopeStageGet research updates
HopeStage
hi@hopestage.com

Built by people with lived experience, between Sydney and Paris.

Back to all studies
CompletedNCT00842309

A study of D-cycloserine Augmentation of Behavior Therapy for Body Dysmorphic Disorder

This study is completed in the United States. It is testing d-cycloserine for Body Dysmorphic Disorder.

Body dysmorphic disorderDrugOver 18 Years
The study in practice

Understand this study

Who could participate?

Listed age limits: from 18 years.

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateNovember 2008
Recruitment status
Completed
Enrollment listed in the registry
68
Sponsor
Massachusetts General Hospital
Sponsor type
Hospital / academic medical center
Study type
Drug
Intervention type
Medication / drug
Study phase
EARLY Phase 1An early first-in-human or very early safety study, usually focused on how a treatment behaves in the body.
Locations
United States
Age range
Over 18 Years
Official registry ID
NCT00842309
Official title
A Randomized, Double-blind, Placebo-controlled Trial of D-cycloserine Augmentation of Behavior Therapy for Body Dysmorphic Disorder

Ask HopeStage to help me review this study

This record does not confirm open recruitment. We can help you understand it and explore other studies.

Loading the security check...
Study ID: NCT00842309. We help you review the study, but cannot decide medical eligibility.

Recruitment & locations

Completed

Boston, United States

Compensation and expense reimbursement have not been verified for this summary.

Checked Official study record (opens in a new tab)
Registry details
Registry conditions (original wording)

Body Dysmorphic Disorder

FAQ

Questions about this study

Who is behind this study?

The study sponsor is Massachusetts General Hospital, a hospital or academic medical center.

Does this study involve medication?

Yes. The study involves medication, including d-cycloserine and Placebo.

Who can participate?

Listed age limits: from 18 years.

Is this study still recruiting?

The registry lists this study as completed.

Explore other studies

Want to find a study that may fit you better?

Answer a few simple questions to explore HopeStage studies by condition, country, and situation.

Find a study that may fit me
Related studies

Explore related studies

Other studies that may be relevant based on condition, country, or study type.